Share-based Payment Arrangement, Expense of Wave Life Sciences Ltd. from 31 Mar 2015 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Wave Life Sciences Ltd. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2015 to 31 Mar 2025.
  • Wave Life Sciences Ltd. Share-based Payment Arrangement, Expense for the quarter ending 31 Mar 2025 was $4,953,000, a 72% increase year-over-year.
  • Wave Life Sciences Ltd. annual Share-based Payment Arrangement, Expense for 2024 was $13,141,000, a 34% increase from 2023.
  • Wave Life Sciences Ltd. annual Share-based Payment Arrangement, Expense for 2023 was $9,795,000, a 43% decline from 2022.
  • Wave Life Sciences Ltd. annual Share-based Payment Arrangement, Expense for 2022 was $17,194,000, a 4.8% increase from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Wave Life Sciences Ltd. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $4,953,000 +$2,072,000 +72% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $2,881,000 +$131,000 +4.8% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $2,750,000 -$1,221,000 -31% 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024 2024 Q1
Q1 2022 $3,971,000 -$92,000 -2.3% 01 Jan 2022 31 Mar 2022 10-Q 03 May 2023 2023 Q1
Q1 2021 $4,063,000 +$64,000 +1.6% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q1 2020 $3,999,000 -$346,000 -8% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q1 2019 $4,345,000 -$85,000 -1.9% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q1 2018 $13,574,000 $4,430,000 +$1,431,000 +48% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019 2019 Q1
Q4 2017 $12,143,000 $3,176,000 +$646,000 +26% 01 Oct 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
Q3 2017 $11,497,000 $3,000,000 +$819,000 +38% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 $10,678,000 $2,968,000 +$1,698,000 +134% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $8,980,000 $2,999,000 +$2,133,000 +246% 01 Jan 2017 31 Mar 2017 10-Q 09 May 2018 2018 Q1
Q4 2016 $6,847,000 $2,530,000 +$1,716,000 +211% 01 Oct 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
Q3 2016 $5,131,000 $2,181,000 +$1,463,000 +204% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017 2017 Q3
Q2 2016 $3,668,000 $1,270,000 +$624,000 +97% 01 Apr 2016 30 Jun 2016 10-Q 09 Aug 2017 2017 Q2
Q1 2016 $3,044,000 $866,000 -$980,000 -53% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q4 2015 $4,024,000 $814,000 01 Oct 2015 31 Dec 2015 10-K 12 Mar 2018 2017 FY
Q3 2015 $718,000 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016 2016 Q3
Q2 2015 $646,000 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016 2016 Q2
Q1 2015 $1,846,000 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016 2016 Q1

Wave Life Sciences Ltd. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $13,141,000 +$3,346,000 +34% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2025 2024 FY
2023 $9,795,000 -$7,399,000 -43% 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
2022 $17,194,000 +$787,000 +4.8% 01 Jan 2022 31 Dec 2022 10-K 04 Mar 2025 2024 FY
2021 $16,407,000 +$2,111,000 +15% 01 Jan 2021 31 Dec 2021 10-K 23 Mar 2023 2022 FY
2020 $14,296,000 -$5,213,000 -27% 01 Jan 2020 31 Dec 2020 10-K 03 Mar 2022 2021 FY
2019 $19,509,000 +$3,913,000 +25% 01 Jan 2019 31 Dec 2019 10-K 04 Mar 2021 2020 FY
2018 $15,596,000 +$3,453,000 +28% 01 Jan 2018 31 Dec 2018 10-K 02 Mar 2020 2019 FY
2017 $12,143,000 +$5,296,000 +77% 01 Jan 2017 31 Dec 2017 10-K 02 Mar 2020 2019 FY
2016 $6,847,000 +$2,823,000 +70% 01 Jan 2016 31 Dec 2016 10-K 01 Mar 2019 2018 FY
2015 $4,024,000 01 Jan 2015 31 Dec 2015 10-K 12 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.